HealthEquity Inc (HQY)
Cash ratio
| Jan 31, 2025 | Jan 31, 2024 | Jan 31, 2023 | Jan 31, 2022 | Jan 31, 2021 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 295,948 | 403,979 | 254,266 | 225,414 | 328,803 |
| Short-term investments | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 156,323 | 117,091 | 131,061 | 153,187 | 204,701 |
| Cash ratio | 1.89 | 3.45 | 1.94 | 1.47 | 1.61 |
January 31, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($295,948K
+ $—K)
÷ $156,323K
= 1.89
HealthEquity Inc's cash ratio has fluctuated over the past five years. The ratio was 1.61 as of January 31, 2021, and decreased to 1.47 by January 31, 2022. However, there was a significant improvement in the cash ratio to 1.94 by January 31, 2023. This improvement continued, with the ratio increasing to 3.45 as of January 31, 2024, indicating a substantial increase in the company's ability to cover its short-term liabilities with its cash and cash equivalents. However, there was a slight dip in the cash ratio to 1.89 by January 31, 2025. Overall, the trend in the cash ratio suggests that HealthEquity Inc has maintained a relatively healthy level of liquidity over the years, although there was some fluctuation in the ratio during this period.
Peer comparison
Jan 31, 2025